Identification of a Novel Class of Farnesylation Targets by Structure-Based Modeling of Binding Specificity
暂无分享,去创建一个
Ora Schueler-Furman | Carol A. Fierke | Nir London | Corissa L. Lamphear | James L. Hougland | O. Schueler‐Furman | C. Fierke | N. London | Ora Schueler‐Furman
[1] D. Andres,et al. Protein farnesyl transferase target selectivity is dependent upon peptide stimulated product release. , 2007, Biochemistry.
[2] S. Maurer-Stroh,et al. Protein Prenyltransferases: Anchor Size, Pseudogenes and Parasites , 2003, Biological chemistry.
[3] L. Beese,et al. Thematic review series: Lipid Posttranslational Modifications. Structural biology of protein farnesyltransferase and geranylgeranyltransferase type I Published, JLR Papers in Press, February 13, 2006. , 2006, Journal of Lipid Research.
[4] P. Casey,et al. Protein prenylation: molecular mechanisms and functional consequences. , 1996, Annual review of biochemistry.
[5] V S Caviness,et al. The adhesion signaling molecule p190 RhoGAP is required for morphogenetic processes in neural development. , 2000, Development.
[6] C J Marshall,et al. Protein prenylation: a mediator of protein-protein interactions. , 1993, Science.
[7] A. Schürmann,et al. Alternative mRNA splicing of the novel GTPase Rab28 generates isoforms with different C-termini. , 1996, European journal of biochemistry.
[8] Xavier Estivill,et al. Intersectin 2, a new multimodular protein involved in clathrin‐mediated endocytosis , 2000, FEBS letters.
[9] Oleksii Nikolaienko,et al. Intersectin multidomain adaptor proteins: regulation of functional diversity. , 2011, Gene.
[10] Nicole Cloonan,et al. Human Sin1 contains Ras-binding and pleckstrin homology domains and suppresses Ras signalling. , 2007, Cellular signalling.
[11] J. Colicelli,et al. Human RAS Superfamily Proteins and Related GTPases , 2004, Science's STKE.
[12] The UniProt Consortium,et al. The Universal Protein Resource (UniProt) 2009 , 2008, Nucleic Acids Res..
[13] S. Sebti,et al. Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies , 2000, Oncogene.
[14] R. Rudolph,et al. Identification of a Disulfide Bridge Essential for Transport Function of the Human Proton-coupled Amino Acid Transporter hPAT1* , 2009, The Journal of Biological Chemistry.
[15] A. Cox,et al. Farnesyltransferase inhibitors: potential role in the treatment of cancer. , 2001, Drugs.
[16] P. Casey,et al. Enzymology and biology of CaaX protein prenylation. , 1999, Recent progress in hormone research.
[17] Pradeep Kota,et al. Identification of a consensus motif in substrates bound by a Type I Hsp40 , 2009, Proceedings of the National Academy of Sciences.
[18] D P Siderovski,et al. Quantitative Analysis of the Effect of Phosphoinositide Interactions on the Function of Dbl Family Proteins* , 2001, The Journal of Biological Chemistry.
[19] Maria João Ramos,et al. Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem. , 2008, Current medicinal chemistry.
[20] C. Fierke,et al. Upstream polybasic region in peptides enhances dual specificity for prenylation by both farnesyltransferase and geranylgeranyltransferase type I. , 2005, Biochemistry.
[21] M. Šantić,et al. Exploitation of conserved eukaryotic host cell farnesylation machinery by an F-box effector of Legionella pneumophila , 2010, The Journal of experimental medicine.
[22] Elisabeth L. Humphris,et al. Prediction of protein-protein interface sequence diversity using flexible backbone computational protein design. , 2008, Structure.
[23] Jens Meiler,et al. A physical model for PDZ-domain/peptide interactions , 2010, Journal of molecular modeling.
[24] Saïd M. Sebti,et al. Searching for the elusive targets of farnesyltransferase inhibitors , 2003, Nature Reviews Cancer.
[25] Nir London,et al. Sub‐angstrom modeling of complexes between flexible peptides and globular proteins , 2010, Proteins.
[26] G. Charron,et al. Lipidation by the Host Prenyltransferase Machinery Facilitates Membrane Localization of Legionella pneumophila Effector Proteins* , 2010, The Journal of Biological Chemistry.
[27] P. Casey,et al. Substrate Binding Is Required for Release of Product from Mammalian Protein Farnesyltransferase* , 1997, The Journal of Biological Chemistry.
[28] Colin A. Smith,et al. Backrub-like backbone simulation recapitulates natural protein conformational variability and improves mutant side-chain prediction. , 2008, Journal of molecular biology.
[29] F. Eisenhaber,et al. Refinement and prediction of protein prenylation motifs , 2005, Genome Biology.
[30] David Baker,et al. Protein Structure Prediction Using Rosetta , 2004, Numerical Computer Methods, Part D.
[31] James R. Apgar,et al. Modeling backbone flexibility to achieve sequence diversity: the design of novel alpha-helical ligands for Bcl-xL. , 2007, Journal of molecular biology.
[32] K. Siminovitch,et al. The Intersectin 2 Adaptor Links Wiskott Aldrich Syndrome Protein (WASp)-mediated Actin Polymerization to T Cell Antigen Receptor Endocytosis , 2001, The Journal of experimental medicine.
[33] Y. Kwaik,et al. Host-Mediated Post-Translational Prenylation of Novel Dot/Icm-Translocated Effectors of Legionella Pneumophila , 2010, Front. Microbio..
[34] Tanja Kortemme,et al. Backbone flexibility in computational protein design. , 2009, Current opinion in biotechnology.
[35] E. Birney,et al. The International Protein Index: An integrated database for proteomics experiments , 2004, Proteomics.
[36] A. Ridley. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. , 2006, Trends in cell biology.
[37] Corissa L. Lamphear,et al. Context-dependent substrate recognition by protein farnesyltransferase. , 2009, Biochemistry.
[38] C. Fierke,et al. Measurement of the alpha-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferase. , 2006, Journal of the American Chemical Society.
[39] D. Baker,et al. Native protein sequences are close to optimal for their structures. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[40] T. Südhof,et al. C2-domains, Structure and Function of a Universal Ca2+-binding Domain* , 1998, The Journal of Biological Chemistry.
[41] David K Williams,et al. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. , 2005, Journal of medicinal chemistry.
[42] David Eisenberg,et al. Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.
[43] F. Tamanoi,et al. A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[44] Yoichi Matsuda,et al. Paired-like homeodomain protein ESXR1 possesses a cleavable C-terminal region that inhibits cyclin degradation , 2004, Oncogene.
[45] Kai Simons,et al. Greasing their way: lipid modifications determine protein association with membrane rafts. , 2010, Biochemistry.
[46] R. Russell,et al. Peptide-mediated interactions in biological systems: new discoveries and applications. , 2008, Current opinion in biotechnology.
[47] P. Casey,et al. Conversion of protein farnesyltransferase to a geranylgeranyltransferase. , 2006, Biochemistry.
[48] P. Casey,et al. Lipid modifications of G proteins. , 1994, Current opinion in cell biology.
[49] Sebastian Maurer-Stroh,et al. Protein prenyltransferases , 2003, Genome Biology.
[50] Stephen B. Long,et al. Reaction path of protein farnesyltransferase at atomic resolution , 2002, Nature.
[51] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[52] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[53] Richard T Eastman,et al. Protein farnesyl transferase inhibitors for the treatment of malaria and African trypanosomiasis. , 2005, Current opinion in investigational drugs.
[54] P. Casey,et al. Kinetic studies of protein farnesyltransferase mutants establish active substrate conformation. , 2003, Biochemistry.
[55] Fernanda L. Sirota,et al. Towards Complete Sets of Farnesylated and Geranylgeranylated Proteins , 2007, PLoS Comput. Biol..
[56] David Baker,et al. Macromolecular modeling with rosetta. , 2008, Annual review of biochemistry.
[57] Jeffrey J. Gray,et al. Identification of structural mechanisms of HIV-1 protease specificity using computational peptide docking: implications for drug resistance. , 2009, Structure.
[58] A. R. Fresht. Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding , 1999 .
[59] James L. Hougland,et al. Synthesis and screening of a CaaL peptide library versus FTase reveals a surprising number of substrates. , 2010, Bioorganic & medicinal chemistry letters.
[60] P. Casey,et al. Crystallographic analysis of CaaX prenyltransferases complexed with substrates defines rules of protein substrate selectivity. , 2004, Journal of molecular biology.
[61] James L. Hougland,et al. Identification of novel peptide substrates for protein farnesyltransferase reveals two substrate classes with distinct sequence selectivities. , 2010, Journal of molecular biology.
[62] Gevorg Grigoryan,et al. Design of protein-interaction specificity affords selective bZIP-binding peptides , 2009, Nature.
[63] Andrea K. Stoddard,et al. A continuous fluorescent assay for protein prenyltransferases measuring diphosphate release. , 2005, Analytical biochemistry.